{
    "medicine_id": "03c3079f5502644b68bd008cadfb5d867d3e8978",
    "platform_id": "DB05444",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v Iroxanadine",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in atherosclerosis and vascular diseases as a cardioprotective agent Its use has also been suggested for the prevention of early restenosis following vascular surgery or balloon angioplasty",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "EC endothelial cell function plays a central role in vascular diseases e g atherosclerosis restenosis diabetic angiopathies microvascular angina peripheral arterial disease BRX 235 induces phosphorylation of p38 SAPK which plays an important role in EC homeostasis",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}